medigraphic.com

2007, Número 1

<< Anterior Siguiente >>

Rev Fac Med UNAM 2007; 50 (1)


Campylobacter y enfermedades asociadas

Cervantes GE, Cravioto QA

Idioma: Español
Referencias bibliográficas: 51
Paginas: 31-35
Archivo PDF: 78.24 Kb.


FRAGMENTO

El término Campylobacter deriva de la palabra griega campylos (curvo) y baktron (bacilo), se le denominó así para distinguirlos del género de los vibrios, cuyo aspecto es muy similar.

La campilobacteriosis es considerada una zoonosis mundial. El género Campylobacter agrupa 18 especies, entre las que destacan Campylobacter jejuni y Campylobacter coli, como agentes importantes de diarrea en el ser humano, y Campylobacter fetus, en pacientes comprometidos.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Smibert RM. Census Campylobacter in Krieg NR, Hutl NG, eds. Bergey’s manual of Systemic Bacteriology, V (1) Baltimore: Williams & Wilkins. 1984.

  2. Butzler JP. Campylobacter, from obscurity to celebrity. Clin Microbiol 2004; 10: 868-876.

  3. Kist M. The historical background of Campylobacter infection: new aspects. In: Pearson AD, editor. Proceedings of the 3rd International Workshop on Campylobacter infections; Ottawa; 1985 Jul 7.10. London; Public Health Laboratory Service; 1985.

  4. McFadyean J, Stockman S. Report of the departamental Comité appointed by the Board of Agricultura and Fisheries to inquire into Epizzotic Abortion. HMSO; 1913.

  5. Smith T. The etiological relation of Spirilla (V, foetus) to bovine abortion. J Exp Med 1919; 30: 313-314.

  6. Stegenga Th, Terpstera JI. Over Vibrio foetus infecties bij het rund en enzootische seriliteit. Tijdschr Diergeneesk 1949; 74: 293-296.

  7. Florent A. Les Deux Vibrioses génitales de la bete bovine: la vibriose vénereinne due a V. fetus venerialisis. Proc 16th Int Vet Congr 1959; 2: 489-493.

  8. Vinzent RM, Dumas J, Picard N. Septicémie grave au cours de la grossesse due a un Vibrion. Avortement consécutif. Bull Acad Nat Med Paris 1947; 131: 90-92.

  9. King EO. Human infections with Vibrio fetus and closely related vibrio. J Infect Dis 1957; 101: 119-128.

  10. King EO. The laboratory recognition of Vibrio fetus and a closely related Vibrio isolated from cases of human vibriosis. Ann NY Acad Sci 1962; 98: 700-711.

  11. Dekeyser P, Gossuin-Detrain M, Butzler JP. Acute enteritis due to a related vibrio: first positive stool cultures. J Infect Dis 1972; 125: 390-392.

  12. Vandamme P, De Ley J. Proposal for a new family, Campylobaceriacear. Int J Syst Bacteriol 1991; 41: 451-455.

  13. Vandamme P. Taxonomy of the family Campylobacteriaceae. In: Nachamkin I, Blaser MJ, eds. Campylobacter, 2nd edn. Washington DC: ASM 2000.

  14. Koneman E, Allen SD, Dowell VR. Color Atlas and Textbook of Diagnostic Microbiology. Lippicot Company, Philadelphia, Pennsylvania. 2000.

  15. Butzler JP, Skirrow MB. Campylobacter enteritis. Clin Gastroenterol 1979; 8: 737-765.

  16. Blaser MJ, Taylor DN, Feldman RA. Epidemiology of Campylobacter jejuni infections. Epidemiol Rev 1983; 5: 157-162.

  17. Tauxe R. Incidence, trends and source of campylobacteriosis in developed countries: an overview. In: The increasing incidence of campylobacteriosis in humans. Report and proceedings of a WHO consultation of experts. Geneva: World Health Organization, 2001.

  18. Calva JJ, Ruiz-Palacios GM. Cohort study of initial infections with Campylobacter in mexican children. Lancet 1988; 1: 503-506.

  19. Coker AO, Isokpehi RD, Thomas BN. Human campylobacteriosis in developing countries. Emerg Infect Dis 2002; 8: 237-244.

  20. Penner JL. The Genus Campylobacter: A decade of progress. Clin Microbiol Rev 1988;1: 157-172.

  21. Skirrow MB. Epidemiology of Campylobacter enteritis. Int J Food Microbiol 1991; 12: 1-8.

  22. Altekruse SF, Stern NJ, Fields PI. Campylobacter jejuni-and emerging foodborne pathogen. Emerg Infect Dis 1999; 5: 28-35.

  23. Frost JA, Gillespie JA, O’Brien SJ. Public health implications of Campylobacter outbreaks and microbiological investigations. Epidemiol Infect 2002; 128: 111-118.

  24. Kapperud G. Campylobacter infection. Epidemiology, risk factors and preventive measures. Tidskr Nor Laegeform 1994; 114: 795-799.

  25. Anonymus. Control and prevention of Campylobacter infections. Suggestions of the design, conduct and analysis of an epidemiological study aimed at identification of risk factors for Campylobacter infections in humans. Geneva: World Health Organization. 1998.

  26. Anonymus. The increasing incidence of human campylobacteriosis. Report and proceedings of a WHO consultation of experts. Geneva: World Health Organization 2001.

  27. Perez-Perez GI, Blaser MJ. Lypopolyscharide characteristics of pathogenic Campylobacter. Infect Immun 1985; 47: 353-359.

  28. Aspinall GO, Fujimoto S, McDonald AG. Lipopolysaccharides from Campylobacter jejuni associated with Guillain-Barré syndrome patients mimic humans ganglioside in structure. Infect Immun 1994; 62: 2122-2125.

  29. Ang CW, Noordzij PG, de Klerk MA. Ganglioside mimicry of Campylobacter jejuni lipopolysaccharide determines antiganglioside specificity in rabbits. Infect Immun 2002; 70: 5081-5085.

  30. Skirrow MB. Campylobacter enteritis a “ne2” disease. BMJ 1977; 2: 9-11.

  31. Wassenaar TM. Toxin production by Campylobacter spp. Clin Microbiol Rev 1997 : 10466-476.

  32. Karmali MA, Fleming PC. Campylobacter enteritis in children. J Pediatr 1979; 94: 527-522.

  33. Crushell E, Harty S, Sharif F. Enteric Campylobacter purging its secrets? Pediatr Res 2004; 55: 3-12.

  34. Tauxe RV. Epidemiology of Campylobacter jejuni infections in the United States and other industrial nations. In: Nachamkin I, Blaser MJ, Tompkins LS, editors. Campylobacter jejuni: current and future trends. Washington. ASM. 1992.

  35. Goosens H, Henocque G, Kremp J. Nosocomial outbreak of Campylobacter jejuni meningitis in newborn infants. Lancet 1986; ii: 146-149.

  36. Vandenberg O, Klein A, Souayah H. Possible Campylobacter jejuni osteomyelitis in a 14 month old child. Int J Infect Dis 2003; 7: 164-165.

  37. Kosuen TV, Kauranem O, Martio J. Reactive arthritis after Campylobacter jejuni enteritis in patients with HLA-B27. Lancet 1980; 1: 1312.

  38. Allos BM, Lippy FT, Carlsen A. Campylobacter jejuni strains from patients with Guillain-Barré syndrome. Emerg Infect Dis 1998; 4: 263-268.

  39. Reis JH, Soudain SE, Gregory NA. Campylobacter jejuni infection and Guillain-Barré syndrome. N Engl J Med 1995; 333: 1374-1379.

  40. Shoenfeld Y, George J, Peter JB. Guillain-Barré as an autoimmune disease, Int Arch Allergy Immunol 1996; 109: 1649-1658.

  41. Yuki N. Infectious origins of, and molecular mimicry in Guillain-Barré and Fisher syndromes. Lancet Infect Dis 2001; 1: 29-37.

  42. Gilbert M, Godschalk PC, Karwaski MF. Evidence for acquisition of lipopolysaccharide biosynthesis locus in Campylobacter jejuni GB 11, a strain isolated from a patient with Guillain-Barré syndrome, bay horizontal exchange. Infect Immun 2004; 72: 1162-1165.

  43. Kaldor J, Speed BR. Guillain-Barré syndrome and Campylobacter jejuni: a serological study. BMJ 1982; 285: 173-174.

  44. Salazar-Lindo E, Sack RB, Chea-Woo E. Early treatment with erythromycin of Campylobacter jejuni associated dysentery in children. J Pediatr 1986; 109: 355-360.

  45. Butzler JP, Mégraud F. Campylobacter and Helycobacter pylori. In: Zinner SH, Young LS, Acar JF, Neu HC eds. Expanding indications for the new macrolides, azalides and streptogramins. New York: Dekker, 1997.

  46. Fernandez H. Emergence of antimicrobial resistance in Campylobacter: the consequences for incidence, clinical course, epidemiology and control. In: The increasing incidence of campylobacteriosis in humans. Report and proceedings of a WHO consultation of experts. Geneva: World Health Organization, 2001.

  47. Smith KE, Besser JM, Hedberg CW. Quinolone resistant Campylobacter jejuni infections in Minnesota, 1992-1998. N Engl J Med 1999; 340: 1525-1532.

  48. Smith KE, Bender JB, Osterholm MT. Antimicrobial resistance in animals and relevance to human in animals and relevance to human infections. In: Nachmakin I, Blaser MJ, eds. Campylobacter, 2nd edn. Washington DC: ASM 2000.

  49. McDermott PF, Bodeis SM, English LL. Cyprofloxacin resistance in Campylobacter jejuni evolves rapidly in chickens treated with fluoroquinolone. J Infect Dis 2002; 185: 837-840.

  50. Parkhill J, Wren BW, Mungall K. The genome sequence of foodborne pathogen Campylobacter jejuni reveals hypervariable sequence. Nature 2000; 403: 66-68.

  51. Scott DA. Vaccines against Campylobacter jejuni. J Infect Dis 1997; 176(S2): S183-S188.




2020     |     www.medigraphic.com